IDNA ETF

IDNA ETF
$35.42
Screen 5,700+ ETFsFind similar ETFs with lower fees
See inside every fund you own
$45/quarter Pro · Cancel anytime
X-ray my whole portfolio

Returns Overview

1 Month
+12.46%
3 Months
+16.55%
6 Months
+28.57%
YTD
+28.18%
1 Year
+63.80%
3 Years (annualized)
+13.63%
5 Years (annualized)
-7.75%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would IDNA have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index(^NYFSGIB)
This ETF (YTD)
+28.18%
Peer Avg (YTD)
+7.57%
vs Peers
+20.61%

IDNA ETF Performance

IDNA performance across multiple time periods: 1-month 12.46%, YTD 28.18%, 1-year 63.80%, 3-year 13.63%, 5-year -7.75%.

IDNA returns outperform the peer average of 7.57% YTD. With an expense ratio of 0.47%, investors should weigh costs against performance when evaluating this ETF.

IDNA vs another fund shows side-by-side returns. IDNA alternatives are available in the ETF Screener.

Compare IDNA

IDNA vs SPYIDNA vs QQQIDNA vs VOOIDNA vs VTIIDNA vs IVVIDNA vs SCHDIDNA vs VYMIDNA vs VXUS

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+12.46%N/A
3 Months+16.55%N/A
6 Months+28.57%N/A
1 Year+63.80%N/A
3 Years+13.63%N/A
5 Years-7.75%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized